IMMCO DIAGNOSTICS, INC.

IMMCO Diagnostics is a clinical reference laboratory located in Buffalo, NY, specializing in serological and biopsy testing for autoimmune diseases and pregnancy-related complications. Licensed throughout the United States, the company offers diagnostic testing for Sjögren's syndrome, Rheumatoid Arthritis, Celiac Disease, Ulcerative Colitis, Crohn's Disease, Systemic Lupus Erythematosus, and Scleroderma. The laboratory is known for developing proprietary biomarkers, including novel SP-1, CA-6, and PSP markers for Sjögren's syndrome that increase diagnostic sensitivity above 80% before traditional antibodies appear. IMMCO also provides preeclampsia risk assessment testing using FDA-cleared biomarkers (sFlt-1 and PlGF) with KRYPTOR instrumentation to guide early clinical intervention and reduce maternal-fetal complications. The company was co-founded by periodontists and maintains specialized Oral and Maxillofacial pathology services with over 40 years' experience; staff includes board-certified oral and immune pathologists offering case consultations and second opinions. Services include individual tests, panels, genetic testing for autoimmune conditions, and family screening. The laboratory operates as a reference service provider, accepting specimens from healthcare providers nationwide.